Molecular Blood Test Diagnoses Herpes Simplex Virus Infection
|
By LabMedica International staff writers Posted on 07 Nov 2012 |
Polymerase chain reaction (PCR) is now the test of choice for identifying central nervous system infection caused by herpes simplex virus (HSV).
A longitudinal review of HSV PCR testing at two pediatric academic medical centers in the USA determined the clinical features of children positive for serum HSV through PCR testing.
Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) in collaboration with others carried out a retrospective review of all patients who had a serum HSV PCR test at the participating institutions from 2005 to 2010. The study focused on children with one positive blood HSV PCR test and reviewed their charts for demographic, clinical, and other data. They defined a neonatal HSV infection as occurring before 42 days of age.
More than 700 patients received blood HSV PCR testing during the study period. Of those children, 294 were infants younger than 42 days old. A positive HSV PCR test was found in 45 patients (6.1%), 21 of whom were infants. Of these infants, approximately 25% were diagnosed with skin, eye, and mouth HSV disease; another 25% were diagnosed with central nervous system HSV disease; and approximately 50% had disseminated HSV disease. One third of the neonatal HSV patients in this study died. For two of those infants, the blood HSV PCR was the only positive HSV test. In another four children, the blood HSV PCR was the first test that was positive.
Among the 24 older children with positive blood HSV PCR tests, 50% were immunocompromised. Another 29% suffered from atopic dermatitis. Mucocutaneous lesions were much more common, occurring in 92% of these older children and 13% of the older children died. In four of the older children, the blood HSV PCR was the only positive test, and it was the first positive test in another seven of these children, all of whom had vesicular lesions that would have clinically suggested an HSV diagnosis. The authors concluded that HSV PCR testing on serum samples can be a useful adjunct in the diagnosis of HSV, especially among young infants who are much less likely than older children to have mucocutaneous lesions. The study was published in the August 2012 edition of the Journal of Pediatrics.
Related Links:
University of Texas Southwestern Medical Center
A longitudinal review of HSV PCR testing at two pediatric academic medical centers in the USA determined the clinical features of children positive for serum HSV through PCR testing.
Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) in collaboration with others carried out a retrospective review of all patients who had a serum HSV PCR test at the participating institutions from 2005 to 2010. The study focused on children with one positive blood HSV PCR test and reviewed their charts for demographic, clinical, and other data. They defined a neonatal HSV infection as occurring before 42 days of age.
More than 700 patients received blood HSV PCR testing during the study period. Of those children, 294 were infants younger than 42 days old. A positive HSV PCR test was found in 45 patients (6.1%), 21 of whom were infants. Of these infants, approximately 25% were diagnosed with skin, eye, and mouth HSV disease; another 25% were diagnosed with central nervous system HSV disease; and approximately 50% had disseminated HSV disease. One third of the neonatal HSV patients in this study died. For two of those infants, the blood HSV PCR was the only positive HSV test. In another four children, the blood HSV PCR was the first test that was positive.
Among the 24 older children with positive blood HSV PCR tests, 50% were immunocompromised. Another 29% suffered from atopic dermatitis. Mucocutaneous lesions were much more common, occurring in 92% of these older children and 13% of the older children died. In four of the older children, the blood HSV PCR was the only positive test, and it was the first positive test in another seven of these children, all of whom had vesicular lesions that would have clinically suggested an HSV diagnosis. The authors concluded that HSV PCR testing on serum samples can be a useful adjunct in the diagnosis of HSV, especially among young infants who are much less likely than older children to have mucocutaneous lesions. The study was published in the August 2012 edition of the Journal of Pediatrics.
Related Links:
University of Texas Southwestern Medical Center
Latest Microbiology News
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
- Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
- Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read moreMolecular Diagnostics
view channel
Urine Test Detects Early Stage Pancreatic Cancer
Pancreatic cancer remains among the hardest cancers to detect early. In the UK, around 10,000 people are diagnosed each year, but only 5% survive beyond five years. Late diagnosis is a major factor—more... Read more
Genomic Test Could Reduce Lymph Node Biopsy Surgery in Melanoma Patients
Accurately determining whether melanoma has spread to the lymph nodes is crucial for guiding treatment decisions, yet the standard procedure—sentinel lymph node biopsy—remains invasive, costly, and unnecessary... Read moreHematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read moreImmunology
view channel
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read more
Signature Genes Predict T-Cell Expansion in Cancer Immunotherapy
Modern cancer immunotherapies rely on the ability of CD8⁺ T cells to rapidly multiply within tumors, generating the immune force needed to eliminate cancer cells. However, the biological triggers behind... Read morePathology
view channel
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read moreTechnology
view channel
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read more
Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
Blood tests remain a cornerstone of medical diagnostics, but traditional imaging and analysis methods can be slow, costly, and reliant on dyes or contrast agents. Now, scientists have developed a real-time,... Read moreIndustry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more








